rmdopen.bmj3d
Combining patient-reported outcome measures to screen for active disease in rheumatoid arthritis and psoriatic arthritis
Objectives To investigate whether a combination of general health (Visual Analogue Scale (VAS)), Health Assessment Questionnaire-Disability Index (HAQ-DI), pain (VAS/Numerical Rating Scale (NRS)), ...
rmdopen.bmj4d
Comorbidity burden on mortality in patients with systemic sclerosis
Introduction Systemic sclerosis (SSc) is a serious life-threatening tissue disease. A significant aspect of its mortality arises from comorbid conditions. Our study aimed at mapping out the prevalence ...
rmdopen.bmj4d
Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next
Diffuse idiopathic skeletal hyperostosis (DISH) is a well-recognised entity characterised by calcifications and ossifications of the entheses affecting mainly the spine and peripheral sites. DISH is ...
rmdopen.bmj4d
EULAR ‘points to consider’ for the conduction of workforce requirement studies in rheumatology
Objective Current methods used for forecasting workforce requirements in rheumatology are disparate, as are the parameters incorporated into workforce projection studies. The objective of these ...
rmdopen.bmj6d
A prediction model for progressive disease in systemic sclerosis
Objective To develop a model that assesses the risk for progressive disease in patients with systemic sclerosis (SSc) over the short term, in order to guide clinical management. Methods Baseline ...